Molecules 2020, 25, 32
9 of 13
1H-NMR and 13C-NMR spectra were recorded by using a 400 MHz Bruker AV3HD-400
spectrometer (Billerica, MA, USA) at 298 K, with tetramethylsilane (TMS, = 0) as the internal
δ
standard. HRMS spectra were acquired by using a Thermo Scientific Q Exactive Plus Orbitrap
LC–MS/MS instrument operating in ESI (Electrospray ionization) mode. UV-visible absorption spectra
were recorded at room temperature on a Cary 300 UV-visible spectrophotometer (Agilent Technologies,
Inc., Santa Clara, CA, USA) equipped with a 1.0 cm quartz cell. Fluorescence emission spectra were
recorded on a Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies, Inc., Santa Clara,
CA, USA) and used 1.0 cm quartz cells. Data were plotted by using Origin 2019.
3.2. Synthesis and Characterization
The general synthetic method of BA-based dyes can be briefly described as follows: aldehyde
compound (1.1 mmol) was added into a 100 mL round-bottom flask and dissolved with 8 mL of
ethanol. Subsequently, equivalent molarity of (substituted) barbituric acid (1 mmol) in 2 mL of hot
water was added, and the mixture was heated up to 60 ◦C and stirred for about 6 h. After cooling, the
resulting solid was collected, washed three times with ice-cold ethanol, and dried over, to afford the
final product.
5-(4-(dimethylamino)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (MeB) (0.23 g, yield 89%).
1H-NMR (400 MHz, DMSO-d6):
δ
(ppm): 10.95 (s, 2H), 8.42 (d, J = 9.2 Hz, 2H), 8.15 (s, 1H),
6.80 (d, J = 9.2 Hz, 2H), 3.12 (s, 6H). 13C-NMR (101 MHz, DMSO-d6):
δ
(ppm): 165.15, 163.18, 155.93,
154.63, 150.76, 139.50, 120.45, 111.66, 110.02. HRMS (ESI-MS): m/z 260.1023, calcd. 259.0957.
5-(4-(dimethylamino)benzylidene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (MeB-M) (0.26 g,
1
yield 92%). H-NMR (400 MHz, DMSO-d6):
δ
(ppm): 8.41 (d, J = 9.3 Hz, 2H), 8.24 (s, 1H), 6.83 (d,
(ppm): 163.71, 161.66,
J = 9.3 Hz, 2H), 3.23 (s, 6H), 3.14 (s, 6H). 13C-NMR (101 MHz, DMSO-d6):
δ
156.79, 154.72, 151.72, 139.57, 120.50, 111.67, 109.80, 28.98, 28.35. HRMS (ESI-MS): m/z 288.1342, calcd.
287.1270.
1
5-(4-morpholinobenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (MoB) (0.23 g, yield 75%). H-NMR
(400 MHz, DMSO-d6):
δ (ppm): 11.06 (d, J = 50.6 Hz, 2H), 8.39 (d, J = 9.1 Hz, 2H), 8.16 (s, 1H), 7.02 (d, J
= 9.2 Hz, 2H), 3.77–3.69 (m, 4H), 3.50–3.43 (m, 4H). 13C-NMR (101 MHz, DMSO-d6): δ (ppm): 164.91,
163.02, 155.66, 154.66, 150.72, 138.99, 122.12, 112.88, 111.97, 66.25, 46.66. HRMS (ESI-MS): m/z 302.1143,
calcd. 301.1063.
1,3-dimethyl-5-(4-morpholinobenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (MoB-M) (0.26 g, yield
1
80%). H-NMR (400 MHz, DMSO-d6):
δ (ppm): 8.41 (d, J = 9.3 Hz, 2H), 8.26 (s, 1H), 7.05 (d, J = 9.3 Hz,
2H), 3.73 (m, 4H), 3.48 (m, 4H), 3.23 (s, 6H). HRMS (ESI-MS): m/z 330.1446, calcd. 329.1376.
5-(4-(pyrrolidin-1-yl)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (PyB) (0.27 g, yield 95%).
1H-NMR (400 MHz, DMSO-d6):
δ
(ppm): 10.94 (d, J = 49.0 Hz, 2H), 8.44 (d, J = 9.1 Hz, 2H),
8.14 (s, 1H), 6.66 (d, J = 9.2 Hz, 2H), 3.44 (t, J = 6.5 Hz, 4H), 1.99 (t, J = 6.6 Hz, 4H). 13C-NMR (101 MHz,
DMSO-d6): (ppm): 165.22, 163.23, 156.00, 152.18, 150.78, 139.79, 120.39, 112.20, 109.37, 48.11, 25.30.
δ
HRMS (ESI-MS): m/z 286.1182, calcd. 285.1113.
1,3-dimethyl-5-(4-(pyrrolidin-1-yl)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (PyB-M) (0.29 g,
1
yield 93%). H-NMR (400 MHz, DMSO-d6): δ (ppm): 8.44 (d, J = 9.1 Hz, 2H), 8.24 (s, 1H), 6.68 (d, J =
9.2 Hz, 2H), 3.46 (m, 4H), 3.23 (s, 6H), 2.00 (s, 4H). 13C-NMR (101 MHz, DMSO-d6):
δ (ppm): 163.76,
161.69, 156.87, 152.28, 151.74, 139.86, 120.45, 112.24, 109.15, 48.15, 28.96, 28.34, 25.30. HRMS (ESI-MS):
m/z 314.1494, calcd. 313.1426.
5-(4-(diethylamino)-2-hydroxybenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione (EtHB) (0.18 g, yield
1
58%). H-NMR (400 MHz, DMSO-d6):
δ (ppm): 10.77 (s, 1H), 8.99 (d, J = 9.5 Hz, 1H), 8.76 (s, 1H),
6.35 (dd, J = 9.6, 2.4 Hz, 1H), 6.16 (d, J = 2.5 Hz, 1H), 3.44 (q, J = 7.0 Hz, 4H), 1.15 (t, J = 7.0 Hz, 6H).